Media coverage about Semler Scientific (NASDAQ:SMLR) has trended somewhat positive recently, according to Accern. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Semler Scientific earned a daily sentiment score of 0.21 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 45.9401388856467 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Shares of Semler Scientific (NASDAQ:SMLR) remained flat at $3.35 during trading on Wednesday. The company had a trading volume of 30 shares. Semler Scientific has a one year low of $1.28 and a one year high of $3.97. The stock’s market cap is $17.89 million. The company has a 50-day moving average of $3.19 and a 200-day moving average of $2.88.
Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported ($0.16) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.11) by $0.05. The firm had revenue of $2.58 million for the quarter, compared to analyst estimates of $2.23 million. On average, analysts expect that Semler Scientific will post ($0.36) EPS for the current year.
COPYRIGHT VIOLATION WARNING: This story was first published by BBNS and is the property of of BBNS. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://baseballnewssource.com/markets/semler-scientific-smlr-given-daily-coverage-optimism-rating-of-0-21-updated-updated/1305540.html.
About Semler Scientific
Semler Scientific, Inc develops, manufactures and markets products and services that assist healthcare insurers and physician groups in evaluating and treating chronic diseases. The Company markets QuantaFlo and WellChec to its customers. QuantaFlo is an approximately four-minute in-office blood flow test.
Receive News & Ratings for Semler Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific Inc and related companies with our FREE daily email newsletter.